Institutional investors purchased a net $8.6 million shares of NVO during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 9.02% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACKSON SQUARE PARTNERS LLC Bought 11.8 Million shares of Novo Nordisk A/S
ARROWSTREET CAPITAL LP Bought 1.6 Million shares of Novo Nordisk A/S
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.4 Million shares of Novo Nordisk A/S